Skip to Main Content
Hospital Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: As we launch new branding in the coming months, you will see updates to the logos. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

  • Benign Prostatic Hypertrophy (6)
  • Cystitis (1)
  • Drug-Induced Nephrotoxicity (71)
  • Drug Use in Renal Insufficiency (156)
    • Bone/Joint and Rheumatology (14)
    • Cardiology (66)
    • Endocrinology (31)
    • Gastroenterology (10)
    • Hematology/Oncology (5)
    • Infectious Diseases (39)
    • Men's Health (1)
    • Neurology/Psychiatry (11)
    • Women's Health (2)
  • Hyperkalemia (9)
  • Hypernatremia (1)
  • Hyponatremia (4)
  • Incontinence (2)
  • Kidney Disease (23)
  • Kidney Stones (15)
  • Nephrology (33)
  • Overactive Bladder (9)
  • Resources (51)
  • Urinary Retention (2)
  • UTIs (52)
  • Urine Drug Testing (8)
16 - 30 of 31 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
PL Voices: Renal Effects of Diabetes Medications August 2016
Article: Stop SGLT2 Inhibitors When Patients Present With Acute Renal Insufficiency August 2016
Article: Don't Use Serum Creatinine Cutoffs Anymore For Metformin June 2016
PL Voices: Appropriate Use of Metformin in Patients with Kidney Disease June 2016
Commentary: Clinical Use of Metformin in Special Populations June 2016
Article: Stop Gliptins in Patients Admitted With Heart Failure July 2015
Other: Adverse Event Reporting Program July 2015
Other: SGLT2 Inhibitors (Flozins) and Ketoacidosis/Urinary Tract Infections (Dec 2015) July 2015
Article: Treat Flozin Ketoacidosis With Your Diabetic Ketoacidosis Protocol July 2015
Article: Use eGFR Instead of Cockcroft Gault for "Flozin" Dosing February 2015
PL Voices: Role of SGLT2 Inhibitors for Type 2 Diabetes October 2014
PL Voices: Gliptins and Cardiovascular Risk November 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved